Skip to main content
Caplight Logo









AMRIF

AMRIF

Private
NijmegenHealthcare & Life Scienceshttps://www.amrif.eu/

Company Overview

AMRIF operates in Healthcare & Life Sciences and is based in Nijmegen. It was founded in 2016.

AMRIF is a biotechnology company that develops RESCAP, an alkaline phosphatase-based oral enzyme supplement intended for the treatment of chronic inflammatory and age-related diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

AMRIF Comparables

Compare AMRIF with similar companies based on industry and business-model similarity.

AMRIF comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Alloksys Life Sciences B.V.
80%
Theriva Biologics
71%
AM-Pharma
71%
Book a demo to see all comparables

For institutional investors. Book with your work email.

AMRIF Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for AMRIF. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

AMRIF Filings

Explore SEC and related filing metadata, where available.

AMRIF filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about AMRIF's valuation, stock price, and market status.

Is AMRIF a public or private company?

AMRIF is a private company.

What is the current stock price of AMRIF?

AMRIF is a private company, so its shares have no public market price. Caplight tracks AMRIF's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is AMRIF worth (valuation)?

Valuation information for AMRIF is not publicly available.

Can I buy AMRIF stock?

AMRIF shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was AMRIF's last funding round?

Funding round information for AMRIF is not publicly available.

Who are the main investors in AMRIF?

Investor information for AMRIF is not publicly disclosed.

Will AMRIF IPO soon?

No public IPO plans have been announced for AMRIF.

How can I track AMRIF secondary market activity?

Caplight tracks bids, offers, and trades in AMRIF's shares on secondary markets.

Firmographic Details

HeadquartersNijmegen
Employee Range3
Year Founded2016
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?